AU2008214471A1 - A method and system for determining a cerebrovascular autoregulation state of a patient - Google Patents
A method and system for determining a cerebrovascular autoregulation state of a patient Download PDFInfo
- Publication number
- AU2008214471A1 AU2008214471A1 AU2008214471A AU2008214471A AU2008214471A1 AU 2008214471 A1 AU2008214471 A1 AU 2008214471A1 AU 2008214471 A AU2008214471 A AU 2008214471A AU 2008214471 A AU2008214471 A AU 2008214471A AU 2008214471 A1 AU2008214471 A1 AU 2008214471A1
- Authority
- AU
- Australia
- Prior art keywords
- patient
- blood pressure
- signal
- oxygen content
- autoregulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000010456 cerebrovascular autoregulation Effects 0.000 title claims description 57
- 238000000034 method Methods 0.000 title claims description 39
- 230000036772 blood pressure Effects 0.000 claims description 77
- 230000004872 arterial blood pressure Effects 0.000 claims description 66
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 66
- 239000001301 oxygen Substances 0.000 claims description 66
- 229910052760 oxygen Inorganic materials 0.000 claims description 66
- 230000002490 cerebral effect Effects 0.000 claims description 57
- 230000010455 autoregulation Effects 0.000 claims description 44
- 238000012545 processing Methods 0.000 claims description 44
- 238000005259 measurement Methods 0.000 claims description 28
- 210000004556 brain Anatomy 0.000 claims description 25
- 238000012806 monitoring device Methods 0.000 claims description 23
- 238000007917 intracranial administration Methods 0.000 claims description 19
- 238000001914 filtration Methods 0.000 claims description 15
- 230000003788 cerebral perfusion Effects 0.000 claims description 14
- 238000005070 sampling Methods 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 11
- 239000008280 blood Substances 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 9
- 238000009530 blood pressure measurement Methods 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 4
- 230000002596 correlated effect Effects 0.000 claims description 3
- 230000000737 periodic effect Effects 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 230000010412 perfusion Effects 0.000 claims description 2
- 230000036962 time dependent Effects 0.000 claims 2
- 206010005746 Blood pressure fluctuation Diseases 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000001042 autoregulative effect Effects 0.000 description 23
- 238000002496 oximetry Methods 0.000 description 17
- 230000003727 cerebral blood flow Effects 0.000 description 15
- 238000012544 monitoring process Methods 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 14
- 208000001953 Hypotension Diseases 0.000 description 13
- 230000004907 flux Effects 0.000 description 13
- 230000036543 hypotension Effects 0.000 description 9
- 208000030886 Traumatic Brain injury Diseases 0.000 description 8
- 230000009257 reactivity Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 230000009529 traumatic brain injury Effects 0.000 description 8
- 206010019196 Head injury Diseases 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 230000003068 static effect Effects 0.000 description 6
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 5
- 230000003728 cerebral autoregulation Effects 0.000 description 5
- 238000007428 craniotomy Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000012935 Averaging Methods 0.000 description 4
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 4
- 229960002428 fentanyl Drugs 0.000 description 4
- 208000021822 hypotensive Diseases 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 229960002725 isoflurane Drugs 0.000 description 4
- 238000006213 oxygenation reaction Methods 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 238000010989 Bland-Altman Methods 0.000 description 3
- 208000028399 Critical Illness Diseases 0.000 description 3
- 108010064719 Oxyhemoglobins Proteins 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000002612 cardiopulmonary effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 210000003625 skull Anatomy 0.000 description 3
- 230000001457 vasomotor Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000010496 Heart Arrest Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002631 hypothermal effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000001272 nitrous oxide Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010022840 Intraventricular haemorrhage Diseases 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010027202 Meningitis bacterial Diseases 0.000 description 1
- 206010058780 Meningitis neonatal Diseases 0.000 description 1
- 238000004497 NIR spectroscopy Methods 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 238000012952 Resampling Methods 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010051895 acute chest syndrome Diseases 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 201000009904 bacterial meningitis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 230000001667 episodic effect Effects 0.000 description 1
- 238000002146 exchange transfusion Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 229940045808 haemophilus influenzae type b Drugs 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 230000003705 neurological process Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- BGSZAXLLHYERSY-XQIGCQGXSA-N vecuronium Chemical compound N1([C@@H]2[C@@H](OC(C)=O)C[C@@H]3CC[C@H]4[C@@H]5C[C@@H]([C@@H]([C@]5(CC[C@@H]4[C@@]3(C)C2)C)OC(=O)C)[N+]2(C)CCCCC2)CCCCC1 BGSZAXLLHYERSY-XQIGCQGXSA-N 0.000 description 1
- 229960003819 vecuronium Drugs 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14553—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs
- A61B5/031—Intracranial pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Neurosurgery (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89914607P | 2007-02-02 | 2007-02-02 | |
| US60/899,146 | 2007-02-02 | ||
| PCT/US2008/000170 WO2008097411A1 (en) | 2007-02-02 | 2008-01-04 | A method and system for determining a cerebrovascular autoregulation state of a patient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2008214471A1 true AU2008214471A1 (en) | 2008-08-14 |
Family
ID=39682000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008214471A Abandoned AU2008214471A1 (en) | 2007-02-02 | 2008-01-04 | A method and system for determining a cerebrovascular autoregulation state of a patient |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8556811B2 (enExample) |
| EP (1) | EP2117422B1 (enExample) |
| JP (1) | JP5598838B2 (enExample) |
| KR (1) | KR20090104917A (enExample) |
| AU (1) | AU2008214471A1 (enExample) |
| CA (1) | CA2677257A1 (enExample) |
| WO (1) | WO2008097411A1 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9042952B2 (en) | 1997-01-27 | 2015-05-26 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
| US20060161071A1 (en) | 1997-01-27 | 2006-07-20 | Lynn Lawrence A | Time series objectification system and method |
| US8932227B2 (en) | 2000-07-28 | 2015-01-13 | Lawrence A. Lynn | System and method for CO2 and oximetry integration |
| US20070191697A1 (en) | 2006-02-10 | 2007-08-16 | Lynn Lawrence A | System and method for SPO2 instability detection and quantification |
| US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
| US7668579B2 (en) | 2006-02-10 | 2010-02-23 | Lynn Lawrence A | System and method for the detection of physiologic response to stimulation |
| EP2117422B1 (en) * | 2007-02-02 | 2015-12-09 | The Johns Hopkins University | A method and system for determining a cerebrovascular autoregulation state of a patient |
| US20080319528A1 (en) * | 2007-06-25 | 2008-12-25 | Abbott Laboratories | Modular endoprosthesis with flexible interconnectors between modules |
| US8275553B2 (en) | 2008-02-19 | 2012-09-25 | Nellcor Puritan Bennett Llc | System and method for evaluating physiological parameter data |
| WO2009137682A1 (en) | 2008-05-07 | 2009-11-12 | Lynn Lawrence A | Medical failure pattern search engine |
| US8926515B2 (en) * | 2008-05-15 | 2015-01-06 | Uab Vittamed | Method and apparatus for continuously monitoring intracranial pressure |
| US7744541B2 (en) | 2008-07-29 | 2010-06-29 | Raba Equity Partners Ii, Llc | Cerebral vascular reactivity monitoring |
| US8216136B2 (en) | 2009-03-05 | 2012-07-10 | Nellcor Puritan Bennett Llc | Systems and methods for monitoring heart rate and blood pressure correlation |
| WO2011057084A2 (en) | 2009-11-05 | 2011-05-12 | Somanetics Corporation | Cerebral autoregulation indices |
| US9000914B2 (en) * | 2010-03-15 | 2015-04-07 | Welch Allyn, Inc. | Personal area network pairing |
| US8907782B2 (en) | 2010-06-30 | 2014-12-09 | Welch Allyn, Inc. | Medical devices with proximity detection |
| US8957777B2 (en) | 2010-06-30 | 2015-02-17 | Welch Allyn, Inc. | Body area network pairing improvements for clinical workflows |
| US9474451B2 (en) * | 2011-04-01 | 2016-10-25 | Raba Equity Partners Ii, Llc | Systems and methods for varying blood flow to identify autoregulatory ranges in a patient |
| WO2013162319A1 (ko) * | 2012-04-27 | 2013-10-31 | 아주대학교산학협력단 | 비침습적 대뇌 관류 증강 장치 |
| US20150327779A1 (en) * | 2012-12-18 | 2015-11-19 | Or-Nim Medical Ltd. | System and method for monitoring blood flow condition in region of interest in patient's body |
| US20140278285A1 (en) * | 2013-03-13 | 2014-09-18 | Vasilis Z. Marmarelis | Method for Quantitative Diagnosis of Cerebrovascular, Neurovascular and Neurodegenerative Diseases via Computation of a CO2 Vasomotor Reactivity Index based on a Nonlinear Predictive Model |
| RU2529379C1 (ru) * | 2013-03-15 | 2014-09-27 | Федеральное государственное бюджетное учреждение "Российский научно-исследовательский нейрохирургический институт имени профессора А.Л. Поленова" Министерства здравоохранения Российской Федерации | Способ диагностики функционального значения внутренней сонной артерии |
| FR3009491B1 (fr) * | 2013-08-07 | 2015-09-04 | Assist Publ Hopitaux De Paris | Solution integree de suivi et de surveillance en temps reel de l'etat pathologique d'un patient cerebro-lese |
| US9888871B2 (en) | 2014-01-28 | 2018-02-13 | Covidien Lp | Methods and systems for determining a venous signal using a physiological monitor |
| US10383579B2 (en) * | 2014-10-16 | 2019-08-20 | Covidien Lp | System and method for monitoring autoregulation |
| US10219705B2 (en) * | 2015-05-08 | 2019-03-05 | Covidien Lp | System and method for identifying autoregulation zones |
| US10194870B2 (en) | 2015-05-27 | 2019-02-05 | Covidien Lp | Systems and methods for optimizing autoregulation measurements |
| US10932724B2 (en) * | 2015-06-17 | 2021-03-02 | Covidien Lp | Systems and methods for monitoring autoregulation using a confidence level |
| US10271779B2 (en) | 2015-06-30 | 2019-04-30 | Covidien Lp | System and method of monitoring autoregulation |
| US10292663B2 (en) * | 2015-06-30 | 2019-05-21 | Covidien Lp | System and method of monitoring autoregulation |
| CN108135505B (zh) | 2015-10-06 | 2021-01-26 | 柯惠有限合伙公司 | 用于利用标准化的局部氧饱和度值监测自动调节的系统和方法 |
| CN108348173A (zh) * | 2015-10-16 | 2018-07-31 | 柯惠有限合伙公司 | 识别自动调节区的系统和方法 |
| US10244978B2 (en) * | 2015-10-19 | 2019-04-02 | Brain Check Medical, LLC | Method for assessment of cerebrovascular regulation |
| CN108348174B (zh) | 2015-10-19 | 2020-12-25 | 柯惠有限合伙公司 | 用于在自动调节监测期间提供血压安全区域指示的系统和方法 |
| US10736578B2 (en) * | 2016-07-14 | 2020-08-11 | Covidien Lp | Systems and methods of monitoring autoregulation |
| US11419506B2 (en) | 2016-08-22 | 2022-08-23 | Covidien Lp | System and method for identifying blood pressure zones during autoregulation monitoring |
| WO2018096631A1 (ja) | 2016-11-24 | 2018-05-31 | オリンパス株式会社 | データ処理装置、コンピュータ読取可能媒体、データ処理方法、及びプログラム |
| WO2018217499A1 (en) * | 2017-05-24 | 2018-11-29 | Covidien Lp | Determining a limit of autoregulation |
| EP3727143B1 (en) * | 2017-12-20 | 2021-11-03 | Edwards Lifesciences Corporation | Autoregulation system and method using tissue oximetry and blood pressure |
| US10610164B2 (en) | 2018-04-25 | 2020-04-07 | Covidien Lp | Determining changes to autoregulation |
| US11026586B2 (en) | 2018-04-25 | 2021-06-08 | Covidien Lp | Determining changes to autoregulation |
| US10674964B2 (en) * | 2018-04-25 | 2020-06-09 | Covidien Lp | Determining changes to autoregulation |
| US10660530B2 (en) | 2018-04-25 | 2020-05-26 | Covidien Lp | Determining changes to autoregulation |
| EP3968854A4 (en) * | 2019-05-16 | 2023-10-18 | University of Pittsburgh - Of the Commonwealth System of Higher Education | SYSTEMS AND METHODS FOR MONITORING INTRACRANIAL COMPLIANCE |
| CN110960226B (zh) * | 2019-12-09 | 2022-07-12 | 海脉医疗科技(天津)有限公司 | 一种组织血氧数据监测电路、方法及装置 |
| US20230109678A1 (en) * | 2021-10-13 | 2023-04-13 | Kaunas University Of Technology | Method and apparatus for human brain neuroprotection during surgery |
| KR102727873B1 (ko) * | 2022-06-30 | 2024-11-08 | 서울대학교병원 | 대뇌 자동조절능 평가 장치 및 방법 |
| TW202439333A (zh) * | 2023-03-17 | 2024-10-01 | 胡漢華 | 評估腦血管病變風險的電子裝置和方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6033366A (en) * | 1997-10-14 | 2000-03-07 | Data Sciences International, Inc. | Pressure measurement device |
| JP3797454B2 (ja) * | 1998-03-03 | 2006-07-19 | 富士写真フイルム株式会社 | 脳内酸素飽和度測定装置 |
| AU2002239360A1 (en) * | 2000-11-28 | 2002-06-11 | Allez Physionix Limited | Systems and methods for making non-invasive physiological assessments |
| US6802812B1 (en) | 2001-07-27 | 2004-10-12 | Nostix Llc | Noninvasive optical sensor for measuring near infrared light absorbing analytes |
| DE10331027B4 (de) * | 2003-07-09 | 2017-06-14 | Seleon Gmbh | Verfahren zur kontinuierlichen zerebralen Autoregulationsüberwachung und Diagnosegerät |
| US8062224B2 (en) * | 2004-10-28 | 2011-11-22 | Uab Vittamed | Method and apparatus for non-invasive continuous monitoring of cerebrovascular autoregulation state |
| EP2117422B1 (en) * | 2007-02-02 | 2015-12-09 | The Johns Hopkins University | A method and system for determining a cerebrovascular autoregulation state of a patient |
-
2008
- 2008-01-04 EP EP08713011.8A patent/EP2117422B1/en not_active Not-in-force
- 2008-01-04 CA CA002677257A patent/CA2677257A1/en not_active Abandoned
- 2008-01-04 WO PCT/US2008/000170 patent/WO2008097411A1/en not_active Ceased
- 2008-01-04 US US12/525,029 patent/US8556811B2/en not_active Expired - Fee Related
- 2008-01-04 JP JP2009548246A patent/JP5598838B2/ja not_active Expired - Fee Related
- 2008-01-04 AU AU2008214471A patent/AU2008214471A1/en not_active Abandoned
- 2008-01-04 KR KR1020097018275A patent/KR20090104917A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2117422A1 (en) | 2009-11-18 |
| KR20090104917A (ko) | 2009-10-06 |
| US20100010322A1 (en) | 2010-01-14 |
| US8556811B2 (en) | 2013-10-15 |
| EP2117422A4 (en) | 2012-09-12 |
| JP2010517618A (ja) | 2010-05-27 |
| WO2008097411A1 (en) | 2008-08-14 |
| JP5598838B2 (ja) | 2014-10-01 |
| CA2677257A1 (en) | 2008-08-14 |
| EP2117422B1 (en) | 2015-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2117422B1 (en) | A method and system for determining a cerebrovascular autoregulation state of a patient | |
| Brady et al. | Continuous time-domain analysis of cerebrovascular autoregulation using near-infrared spectroscopy | |
| Andropoulos et al. | Regional low-flow perfusion provides comparable blood flow and oxygenation to both cerebral hemispheres during neonatal aortic arch reconstruction | |
| Hoffman | Pro: near-infrared spectroscopy should be used for all cardiopulmonary bypass | |
| Pellicer et al. | Postnatal adaptation of brain circulation in preterm infants | |
| Finucane et al. | Neuromonitoring modalities in pediatric cardiac anesthesia: a review of the literature | |
| Said et al. | Validation of near infrared spectroscopy to measure abdominal somatic tissue oxygen saturation in neonates | |
| Tyree et al. | Correlation of brain tissue oxygen tension with cerebral near-infrared spectroscopy and mixed venous oxygen saturation during extracorporeal membrane oxygenation | |
| Fraser Jr et al. | Neurologic monitoring for special cardiopulmonary bypass techniques | |
| Webster | Monitoring the critically ill patient. | |
| Ricci et al. | Near-infrared spectroscopy to monitor cerebral oxygen saturation in single-ventricle physiology | |
| Tweddell et al. | All This Monitoring… What’s Necessary, What’s Not? | |
| Donnelly et al. | How to use near-infrared spectroscopy | |
| Pichler et al. | Body position-dependent changes in cerebral hemodynamics during apnea in preterm infants | |
| Tsang | Hemodynamic monitoring in the cardiac intensive care unit | |
| Baenziger et al. | Oxygen extraction index measured by near infrared spectroscopy-a parameter for monitoring tissue oxygenation? | |
| Li et al. | Cardiac output measurement using a modified carbon dioxide Fick method: comparison analysis with pulmonary artery catheter method and pulse induced contour cardiac output method | |
| Li et al. | Functional near infrared spectroscopy in the noninvasive assessment of brain death | |
| Davies et al. | In-Ear Measurement of Blood Oxygen Saturation: An Ambulatory Tool Needed To Detect The Delayed Life-Threatening Hypoxaemia in COVID-19 | |
| Marchionni et al. | Effect of limbs' motion on pulse oximetry in preterm infants | |
| Nicklin et al. | Neonatal intensive care monitoring | |
| Frost | Cerebral oximetry: a replacement for pulse oximetry | |
| Højlund Rasmussen et al. | Influence of upper body position on middle cerebral artery blood velocity during continuous positive airway pressure breathing | |
| Reinhart et al. | Indications and limitations of SvO2 and ScvO2 monitoring | |
| Colon et al. | Monitoring: Technique and Clinical Application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE APPLICANT NAME FROM JOHNS HOPKINS UNIVERSITY TO THE JOHNSHOPKINS UNIVERSITY |
|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |